Updated array supports clinical researchers that aim to improve medication management and eliminate adverse drug reactions.
Genomic sequencing is giving families hope in the face of uncertainty at Children’s Mercy Hospital in Kansas City
Second FDA amendment leverages the power of additional Illumina sequencers for COVID-19 testing
The who’s who in genomics, healthcare, and technology convene for Illumina’s first global idea forum, SPARK
Empowering students to envision themselves as future scientists, innovators, and trailblazers
| Date | Publication | Title |
|---|---|---|
| Apr 30, 2021 | Medtech Dive | Illumina sues European Commission to block competition probe into Grail buyout |
| Apr 30, 2021 | Socal Tech | Illumina Donates $60M To Pathogen Genomics Effort |
| Apr 29, 2021 | Fierce Biotech | Illumina sues European Commission to stop investigation of $8B Grail acquisition |
| Apr 29, 2021 | GenomeWeb | Illumina Challenges European Commission's Jurisdiction Over Review of Grail Acquisition in EU General Court |
| Apr 29, 2021 | Times of San Diego | Illumina Donates $60 Million in Genetic Sequencing to Increase Global Tracking of New Pathogens |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.
